Loading provider…
Loading provider…
Ophthalmology Physician in Poughkeepsie, NY
NPI: 1316957350Primary Practice Location
Central New York Eye Center, Ltd
22 Green St, Poughkeepsie, NY
Primary Employer
Alterman Modi & Wolter Ophthalmic Physicians & Surgeons PLLC
seeta-eye-care-center.com
HQ Phone
Get MD Satish's Phone Numberphone_androidMobile
Get MD Satish's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Seth G.S. Medical College
Medical School
Until 1970
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92250Photography of the retina | 281 | 288 |
| 2 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 187 | 189 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 181 | 184 |
| 4 | 92136Measurement of corneal curvature and depth of eye | 137 | 226 |
| 5 | 92134Diagnostic imaging of retina | 130 | 133 |
Authors: Bret Fisher, Robert Lehmann, Richard Roth
Journal: J Cataract Refract Surg
Publication Date: 2025-04-25
Authors: Joseph Martel, Robert Lehmann, Louis Alpern, Glenn Jaffe, Kevin Jong
Journal: Ophthalmology
Publication Date: 2017-03-06
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.
Authors: Robert Lehmann, Lawrence Roel
Publication Date: 2013-06-11
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: 0.02% Betamethasone Sodium Phosphate, DRUG: 0.04% Betamethasone Sodium Phosphate
Lead Sponsor: AcuFocus, Inc.
Intervention / Treatment: DEVICE: Control Group, DEVICE: IC-8 IOL Group